Seaport Therapeutics, Inc. · NASDAQ:SPTX
Zohar Daphne reported a 9.10% stake in Seaport Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 5, 2026
Zohar Daphne reported a 9.10% stake in Seaport Therapeutics, Inc., 5,225,497 shares, as a passive investor on Jun 30, 2026. Filed Aug 5, 2026 (Schedule 13G).
- Stake
- 9.10%
- Shares
- 5,225,497
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Zohar Daphne | 9.10% | 5,225,497 |
Source
Related
- Seaport Therapeutics, Inc.
- Zohar Daphne
- Seaport Therapeutics, Inc. shareholders
- Schedule 13G · PureTech Health plc · Aug 14, 2026
- Schedule 13G · Paul Steven M · Aug 5, 2026
- Form 4 · Hombach Robert J. · Jun 24, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 11, 2026
- Schedule 13D · General Atlantic, L.P. · May 11, 2026